Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
| Autor: | Noureddin, Mazen *, Khan, Shaharyar, Portell, Francisco, Jorkasky, Diane, Dennis, Jameel, Khan, Omer, Johansson, Lars, Johansson, Edvin, Sanyal, Arun J |
|---|---|
| Zdroj: | In The Lancet Gastroenterology & Hepatology December 2023 8(12):1094-1105 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|